about camurus news products technologies partnering contact about camurus Delivering better treatments Camurus is a research focused pharmaceutical company with a firm commitment to the development and commercialization of innovative specialty medicines that provide patients, suffering from serious disease, with better treatment outcomes and quality of life. Based on our leading research, development capacity, and proprietary FluidCrystal® drug delivery technologies, Camurus is well positioned in its strive to create simpler, smarter and safer specialty medications for treatment of serious and chronic diseases, including cancer, pain and addiction. To extend our development capacity and commercial reach, Camurus also engages actively in strategic partnerships and collaborations with pharmaceutical corporations and research organizations worldwide. History Camurus was founded in 1991 by leading scientists in biophysical chemistry in collaboration with a local entrepeneur. Being pioneers in the research of lipid phase nanostructures and aware of the challenges in pharmaceutical development, they recognized the potential of lyotropic liquid crystal structures for solubilization, stabilization and delivery of active pharmaceutical substances. Today, Camurus has transformed its scientific expertise and proprietary technologies into a promising late-stage pipeline of in-house and partnered products. Executive management team › Board of directors › › UP Innovative nanoscale therapeutics © 2014 Camurus AB home about camurus news products technologies partnering career press contact This website contains information on products which is targeted to a wide audiences and could contain details or information other wise not accessible or valid in your country. Please be aware that we do not take any responibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your region. legal notice privacy policy sitemap Login